SCHEMBL3502011

SCHEMBL3502011

C=C(CCCO)C(=O)OP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 2/20 0.44
ESR1 P03372 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CDC25A P30304 1/20 0.44
AGTR1 P30556 1/20 0.44
AKT1 P31749 1/20 0.44
ADRA1A P35348 1/20 0.44
KCNH2 Q12809 1/20 0.44
PLA2G1B P04054 1/20 0.39
PLA2G2A P14555 1/20 0.39
NR5A2 O00482 1/20 0.39
NR5A1 Q13285 1/20 0.39
ADRA1D P25100 1/20 0.38
PTAFR P25105 1/20 0.38
HTR1D P28221 1/20 0.38
HTR2C P28335 1/20 0.38
ADRA1B P35368 1/20 0.38
DRD3 P35462 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL15862264 0.82 SMN1; SMN2 (0.48) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL3524266 0.80 SMN1; SMN2 (0.48) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL4299694 0.76 LMNA (0.52) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL8679882 0.76 LMNA (0.67) SMN1; SMN2LMNAESR1ADORA3CDC25A
Ethylene Glycol SCHEMBL2050406 0.73 SMN1; SMN2 (0.48) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL19767750 0.73 LMNA (0.73) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL8911477 0.73 LMNA (0.53) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL1853865 0.72 SMN1; SMN2 (0.70) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL10600208 0.72 CAMK2A (0.37)
SCHEMBL15158309 0.71 LMNA (0.59) SMN1; SMN2LMNAESR1ADORA3CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846021-B2 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation OLIGASIS, LLC (US) 2014-09-30 US claimed
US-20220096643-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation KODIAK SCIENCES INC (US) 2022-03-31 US disclosed
EP-1988910-B1 ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION KODIAK SCIENCES INC (US) 2017-12-06 EP disclosed
EP-3222142-A1 ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION Kodiak Sciences Inc. (US) 2017-09-27 EP disclosed
US-20150050714-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation OLIGASIS, LLC (US) 2015-02-19 US disclosed
US-8846021-B2 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation OLIGASIS, LLC (US) 2014-09-30 US disclosed
US-20130337534-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation OLIGASIS, LLC (US) 2013-12-19 US disclosed
US-20100166700-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation OLIGASIS CORPORATION (US) 2010-07-01 US disclosed
EP-1988910-A2 ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION Oligasis Corporation (US) 2008-11-12 EP disclosed
WO-2007100905-A2 ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION NEXGEN THERAPEUTICS, LLC (US) 2007-09-07 WO disclosed
WO-2007100902-A2 ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION OLIGASIS CORPORATION (US) 2007-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100166700-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation PHOSPHO1, PCTP, SGMS1 SMN1; SMN2 1755/4885LMNA 1276/4885ESR1 4057/4885
US-20220096643-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation PHOSPHO1, PCTP, SGMS1 SMN1; SMN2 1755/4885LMNA 1276/4885ESR1 4057/4885
US-20130337534-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation PHOSPHO1, PCTP, SGMS1 SMN1; SMN2 1755/4885LMNA 1276/4885ESR1 4057/4885
US-20150050714-A1 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation PHOSPHO1, PCTP, SGMS1 SMN1; SMN2 1755/4885LMNA 1276/4885ESR1 4057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.